IP Library › Granted Patent US 12,198,334
Granted Patent B2
US 12,198,334 · App. 17/600,703 · Granted Jan 14, 2025

Method for detecting radiological progression in cancer surveillance

Inventors: Hassan Fathallah-Shaykh (Birmingham, AL); Nidhal Bouaynaya (Voorhees, NJ)
Assignees: The UAB Research Foundation; Rowan University
G06T7/0012A61B5/4842G06T7/62G16H50/30G06T2207/10088G06T2207/10104G06T2207/30096
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,198,334
App. No.
17/600,703
Granted
Jan 14, 2025
Kind
B2
Abstract

A method and computer-based system is provided that assists physicians in detecting early tumor growth and allowing modification of treatment to have a positive impact on medical management, patient morbidity, outcomes and survival times. The method comprises measuring tumor volumes from radiological images to predict growth by a statistical method. The methods allow detection of increases in tumor size earlier than is currently possible and, therefore, advantageous in modifying or optimizing treatment.

Claims (12)

1. A method for determining tumor status in a subject, the method comprising the steps of:

(a) obtaining a first plurality of sectional images of a low-grade solid tumor in a human or animal subject;

(b) computing a first volume of the tumor from the first plurality of sectional images;

(c) obtaining a second plurality of sectional images of the tumor after a period from step (a);

(d) computing a second volume of the tumor from the second plurality of sectional images;

(e) determining the extent of tumor increase by comparing the first volume of the tumor from step (b) with the second volume of the tumor volume in step (d) by applying an online abrupt change-of-point method to the plurality of sectional images; and

(f) modifying a treatment protocol of the human or animal patient to reduce at least one of (i) the rate of increase of the tumor volume and (ii) the volume of the tumor.

2. The method of claim 1 , wherein the plurality of sectional images from the subject are generated with an imaging scanner.

3. The method of claim 1 , wherein the plurality of sectional images are magnetic resonance images, positron emission tomography images, or computer tomography images.

4. The method of claim 1 , wherein in step (a) and (c) the human or animal subject is administered a contrast agent that enhances the plurality of images of the tumor.

5. The method of claim 1 , wherein the tumor is a tumor of the brain.

6. The method of claim 5 , wherein the tumor is an oligodendroglioma or an astroglioma.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2022
From: FATHALLAH-SHAYKH, HASSAN
To: THE UAB RESEARCH FOUNDATION
Reel/Frame 058529/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 3, 2022
From: BOUAYNAYA, NIDHAL
To: ROWAN UNIVERSITY
Reel/Frame 058529/0175 →
Continuity (3)
Provisional Application 62828871 · Apr 3, 2019
Provisional Application 62828239 · Apr 2, 2019
Related Publication 20220172359A1 · Jun 2, 2022
References Cited (33)
US 20070027408A1 · Fitzgerald et al. · 2007 [cited by applicant]
US 20150165225A1 · Nadobny · 2015 [cited by examiner]
US 20160296126A1 · Berry · 2016 [cited by examiner]
US 20170238867A1 · Javed · 2017 [cited by examiner]
US 20180042567A1 · Smith · 2018 [cited by examiner]
International Search Report and Written Opinion for PCT/US2020/0205931 mailed on Jun. 17, 2020. [cited by applicant]
Rasmussen BK, et al., “Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry”,. J Neurooncol. 2017;135(3):571-9. Epub Sep. 2, … [cited by applicant]
Berntsson S G., et al. “Glioma-related seizures in relation to histopathological subtypes: a report from the glioma International case-control study”. J Neurol. 2018;265(6):1432-42. Epub Apr. 25, 2018. doi: 10.1007/s004… [cited by applicant]
Bynevelt M et al., “FLAIR imaging in the follow-up of low-grade gliomas: time to dispense with the dual-echo”? Neuroradiology. 2001;43(2):129-33. Epub May 1, 2001. PubMed PMID: 11326557. [cited by applicant]
Delgado-Lopez PD, “Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies”., Clin Transl Oncol. 2017;19(8):931-44. Epub Mar. 4, 2017. doi: 10.1007/s1209… [cited by applicant]
Buckner J., et al., “Management of diffuse low-grade gliomas in adults—use of molecular diagnostics”., Nat Rev Neurol. 2017;13(6):340-51. Epub May 13, 2017. doi: 10.1038/nmeurol.2017.54. PubMed PMID: 28497806. [cited by applicant]
Le Rhun E., “Current Management of Adult Diffuse Infiltrative Low Grade Gliomas”., Curr Neurol Neurosci Rep. 2016;16(2):15. Epub Jan. 12, 2016. doi: 10.1007/s11910-015-0615-4. PubMed PMID: 26750130. [cited by applicant]
Claus EB., et al., “Survival rates in patients with low-grade glioma after intraoperative magnetic resonance image guidance”., Cancer. 2005;103(6):1227-33. Epub Feb. 4, 2005. doi: 10.1002/cncr.20867. PubMed PMID: 156903… [cited by applicant]
Johannesen TB. et al., “Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993”., J Neurosurg… [cited by applicant]
McGirt MJ., et al., “Independent association of extent of resection with survival in patients with malignant brain astrocytoma”, J Neurosurg. 2009;110(1):156-62. Epub Oct. 14, 2008. doi: 10.3171/2008.4.17536. PubMed PMI… [cited by applicant]
Nakamura M., et al., “Analysis of prognostic and survival factors related to treatment of low-grade astrocytomas in adults”., Oncology. 2000;58(2):108-16. Epub Mar. 8, 2000. doi: 10.1159/000012087. PubMed PMID: 10705237. [cited by applicant]
Ahmadi R, et al., “Long-term outcome and survival of surgically treated supratentorial low-grade glioma in adult patients”., Acta Neurochir (Wien). 2009;151(11):1359-65. Epub Jul. 4, 2009/. doi: 10.1007/s00701-009-0435-… [cited by applicant]
Smith JS., et al., “Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas”., J Clin Oncol. 2008;26(8):1338-45. Epub Mar. 8, 2008. doi: 10.1200/JCO.2007.13.9337. PubMed PMID: 18323558. [cited by applicant]
Sanai N., “Glioma extent of resection and its impact on patient outcome”., Neurosurgery. 2008;62(4):753-64; discussion 264-6. Epub May 23, 2008. doi: 10.1227/01.neu.0000318159.21731.cf. PubMed PMID: 18496181. [cited by applicant]
Surma-aho O., “Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients”. Neurology. 2001;56(10):1285-90. Epub May 29, 2001. PubMed PMID: 11376174. [cited by applicant]
Lena Ek, et al., “Decline in executive functions and speed in suspected low-grade gliomas: A 3-year follow-up of a clinical cohort”., Appl Neuropsychol Adult. 2018;25(4):376-84. Epub May 4, 2017. doi: 10.1080/23279095.2… [cited by applicant]
Reijneveld Jaap C., et al., Health-related quality of life in patients with high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study., Lancet Oncol. 2016; 17(11):1533-42. Epub O… [cited by applicant]
Scribner E., et al., “Key rates for the grades and transformation ability of glioma: model simulations and clinical cases”., J Neurooncol. 2017;133(2):377-88. Epub Apr. 30, 2017. doi: 10.1007/s11060-017-2444-6. PubMed P… [cited by applicant]
Baumert B. G., et al., “Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study”., Lancet Oncol. 2016;17(11):1521-32. Epub Oct.… [cited by applicant]
Jhaveri J., et al., “Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base”., Cancer. 2018;124(6):1169-78. Epub Dec. 6, 201… [cited by applicant]
Wang S. et al., “Pathological Brain Detection by Artificial Intelligence in Magnetic Resonance Imaging Scanning”,. Progress In Electromagnetics Research., 2016;156:105-33. doi: 10.2528/PIER16070801. [cited by applicant]
Dera D. et al., “Automated Robust Image Segmentation: Level Set Method Using Nonnegative Matrix Factorization with Application to Brain MRI”., Bull Math Biol. 2016;78(7):1450-76. Epub Jul. 16, 2016. doi: 10.1007/s11538-… [cited by applicant]
Darkhovski Boris S., “Nonparametric Methods in Change-Point Problems: A General Approach and Some Concrete Algorithms”, Lecture Notes-Monograph Series , 1994, vol. 23, Change-Point Problems (1994), pp. 99-107, Institute… [cited by applicant]
Killick R FP, Eckley I., “Optimal detection of changepoints with a linear computational cost”. Journal of the American Statistical Association., 2012;107(500):1590-8. [cited by applicant]
Kerkhof M. et al., “Interobserver variability in the radiological assessment of magnetic resonance imaging (MRI) Including perfusion MRI in glioblastoma multiforme”., Eur J Neurol. 2016;23(10):1528-33. Epub Jul. 19, 201… [cited by applicant]
Bakas S, et al., Identifying the Best Machine Learning Algorithms for Brain Tumor Segmentation, Progression Assessment, and Overall Survival Prediction in the BRATS Challenge. arXiv:181102629. 2018. [cited by applicant]
Scribner E., “Effects of anti-angiogenesis on glioblastoma growth and migration: model to clinical predictions”. PLoS One. 2014;9(12):e115018. Epub Dec. 17, 2014. doi: 10.1371/journal.pone.0115018. PubMed PMID: 25506702… [cited by applicant]
Raman F., et al., “Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme”., PLoS One. 2016;11(1):e0146617. Epub Jan. 13, 2016/01/13. doi: 10.1371/j… [cited by applicant]